The Cost Effectiveness of Implementation of a Postoperative Endocrinopathy Management Protocol after Resection of Pituitary Adenomas

Abstract

Purpose After developing a protocol for evaluating, diagnosing, and treating postoperative endocrinopathy both during the hospitalization and during the immediate discharge period following resection of pituitary adenomas, we sought to assess the impact of this protocol on quality outcomes.

Methods An IRB-exempt, quality improvement initiated, Health Insurance Portability and Accountability Act (HIPAA)-compliant retrospective comparison of a pre-and-post-protocol cohort of all patients undergoing endoscopic endonasal resection of pituitary adenomas at NYU Langone Medical Center from January 2013 to December 2018. Demographic characteristics of the patients and their tumors with their postoperative outcomes were recorded. Quality outcomes regarding number of laboratory studies sent, rate of diabetes insipidus, length of stay, and readmission rate were also recorded. Statistical analysis was performed between the pre- and post-protocol groups.

Results There was a significant reduction in laboratory studies sent per patient (55.66 vs. 18.82, p <0.001). This corresponded with an overall cost reduction in laboratory studies of $255.95 per patient. There was a decrease in the overall number of patients treated with DDAVP (21.4% in the pre-protocol group vs. 8.9% in the post-protocol group, p = 0.04). All post-protocol patients requiring DDAVP at discharge were identified by 48 hours. There was no significant change in length of stay or need for hydrocortisone supplementation postoperatively between the two groups. Length of stay was driven mostly by need for reoperation during initial hospitalization. There was no significant change in the rate of 30-day readmission.

Conclusion Implementation of a postoperative management protocol results in a more efficient diagnosis and management of endocrinopathy after pituitary adenoma surgery which translates to decreased cost.

Keywords

pituitary adenoma - endoscopic endonasal surgery - quality improvement - safety - cost effectiveness

Note

Portion of this work was presented at the NASBS Meeting in Orlando, Florida.

Publication History

Received: 07 October 2021

Accepted: 23 May 2022

Article published online:
29 June 2022

• References

• 1 Prete A, Corsello SM, Salvatori R. Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab 2017; 8 (03) 33-48
• 2 McLaughlin N, Cohan P, Barnett P, Eisenberg A, Chaloner C, Kelly DF. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts. World Neurosurg 2013; 80 (05) 569-575
• 3 Cote DJ, Dasenbrock HH, Muskens IS. et al. Readmission and other adverse events after transsphenoidal surgery: prevalence, timing, and predictive factors. J Am Coll Surg 2017; 224 (05) 971-979
• 4 Burke WT, Cote DJ, Iuliano SI, Zaidi HA, Laws ER. A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery. Pituitary 2018; 21 (01) 25-31
• 5 Liu Y, Zheng T, Lv W. et al. Ambulatory surgery protocol for endoscopic endonasal resection of pituitary adenomas: a prospective single-arm trial with initial implementation experience. Sci Rep 2020; 10 (01) 9755
• 6 Hunsaker JC, Khan M, Gamblin A, Karsy M, Couldwell WT. Use of a surgical stepdown protocol for cost reduction after transsphenoidal pituitary adenoma resection: a case series. World Neurosurg 2021; 152: e476-e483
• 7 Araujo-Castro M, Pascual-Corrales E, Martínez San Millan J. et al. Multidisciplinary protocol of preoperative and surgical management of patients with pituitary tumors candidates to pituitary surgery. Ann Endocrinol (Paris) 2021; 82 (01) 20-29
• 8 Ajlan AM, Abdulqader SB, Achrol AS. et al. Diabetes insipidus following endoscopic transsphenoidal surgery for pituitary adenoma. J Neurol Surg B Skull Base 2018; 79 (02) 117-122
• 9 Dumont AS, Nemergut II EC, Jane Jr JA, Laws Jr ER. Postoperative care following pituitary surgery. J Intensive Care Med 2005; 20 (03) 127-140
• 10 Sigounas DG, Sharpless JL, Cheng DM, Johnson TG, Senior BA, Ewend MG. Predictors and incidence of central diabetes insipidus after endoscopic pituitary surgery. Neurosurgery 2008; 62 (01) 71-78 , discussion 78–79
• 11 Cappabianca P, Cavallo LM, Colao A, de Divitiis E. Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg 2002; 97 (02) 293-298
• 12 Gondim JA, Almeida JP, Albuquerque LA. et al. Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients. Pituitary 2011; 14 (02) 174-183
• 13 Cusick JF, Hagen TC, Findling JW. Inappropriate secretion of antidiuretic hormone after transsphenoidal surgery for pituitary tumors. N Engl J Med 1984; 311 (01) 36-38
• 14 Kelly DF, Laws Jr ER, Fossett D. Delayed hyponatremia after transsphenoidal surgery for pituitary adenoma. Report of nine cases. J Neurosurg 1995; 83 (02) 363-367
• 15 Taylor SL, Tyrrell JB, Wilson CB. Delayed onset of hyponatremia after transsphenoidal surgery for pituitary adenomas. Neurosurgery 1995; 37 (04) 649-653 , discussion 653–654
• 16 Whitaker SJ, Meanock CI, Turner GF. et al. Fluid balance and secretion of antidiuretic hormone following transsphenoidal pituitary surgery. A preliminary series. J Neurosurg 1985; 63 (03) 404-412
• 17 Bohl MA, Ahmad S, White WL, Little AS. Implementation of a postoperative outpatient care pathway for delayed hyponatremia following transsphenoidal surgery. Neurosurgery 2018; 82 (01) 110-117
• 18 Arieff AI. Hyponatremia associated with permanent brain damage. Adv Intern Med 1987; 32: 325-344
• 19 Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) 1976; 55 (02) 121-129
• 20 Vingerhoets F, de Tribolet N. Hyponatremia hypo-osmolarity in neurosurgical patients. “Appropriate secretion of ADH” and “cerebral salt wasting syndrome.”. Acta Neurochir (Wien) 1988; 91 (1-2): 50-54
• 21 Perez-Vega C, Tripathi S, Domingo RA. et al. Fluid restriction after transsphenoidal surgery for the prevention of delayed hyponatremia: a systematic review and meta-analysis. Endocr Pract 2021; 27 (09) 966-972